ProfileGDS4132 / 203443_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 63% 72% 70% 70% 74% 72% 68% 63% 65% 69% 65% 65% 66% 72% 67% 63% 66% 68% 65% 74% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101179.86963
GSM201543Muscle PCOS pioglitazone 121207.75372
GSM201544Muscle PCOS pioglitazone 161213.57970
GSM201545Muscle PCOS pioglitazone 201224.04870
GSM201829Muscle PCOS pioglitazone 231242.5474
GSM201830Muscle PCOS pioglitazon 251228.16872
GSM201831Muscle PCOS pioglitazone 271207.8868
GSM201832Muscle PCOS pioglitazone 31172.18663
GSM201833Muscle PCOS pioglitazone 41177.65565
GSM201834Muscle PCOS pioglitazone 81202.6169
GSM201835Muscle PCOS after pioglitazone 102176.24565
GSM201836Muscle PCOS after pioglitazone 122180.6365
GSM201837Muscle PCOS after pioglitazone 162173.42366
GSM201838Muscle PCOS after pioglitazone 202216.28372
GSM201839Muscle PCOS after pioglitazone 232193.66667
GSM201840Muscle PCOS after pioglitazone 252178.7763
GSM201841Muscle PCOS after pioglitazone 272177.03466
GSM201842Muscle PCOS after pioglitazone 32175.28468
GSM201843Muscle PCOS after pioglitazone 42180.43365
GSM201844Muscle PCOS after pioglitazone 82239.27974